Indication
vulvar intraepithelial neoplasia
2 clinical trials
4 products
Product
ArtesunateProduct
PlaceboClinical trial
A Phase II Double-blind, Placebo-controlled, Randomized Trial of Topical Artesunate Ointment for the Treatment of Patients With Vulvar High-grade Squamous Intraepithelial Lesions (Vulvar HSIL)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase III, Randomized, Blinded, Positive-controlled Study to Compare the Immunogenicity of Zerun 9-valent Human Papillomarivus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Pichia Pastoris) in Healthy Female Subjects Aged 16-26 Years.Status: Active (not recruiting), Estimated PCD: 2023-06-01
Product
Gardasil 9Product
Zerun HPV-9